Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Bugianesi

Showing results (21-30 of 326) with videos related to

Pageof 33
Sort By:
Current Diabetes Reports|June 6, 2007
NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetesElisabetta Bugianesi, Ester Vanni, Giulio Marchesini
The American Journal of Gastroenterology|March 15, 2018
Reply to "Definition of Small for Gestational Age and Low Birthweight"Valerio Nobili, Antonella Mosca, Elisabetta Bugianesi
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 29, 2015
Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?Ester Vanni, Elisabetta Bugianesi, Giorgio Saracco
Liver International : Official Journal of the International Association for the Study of the Liver|October 16, 2024
Impact of PNPLA3 I148M on Clinical Outcomes in Patients With MASLDSalvatore Petta, Angelo Armandi, Elisabetta Bugianesi
Annual Review of Medicine|October 17, 2015
Liver Cancer: Connections with Obesity, Fatty Liver, and CirrhosisAndrea Marengo, Chiara Rosso, Elisabetta Bugianesi
Annals of Medicine|September 24, 2005
Is liver disease a threat to patients with metabolic disorders?Giulio Marchesini, Gabriele Forlani, Elisabetta Bugianesi
Hepatology (Baltimore, Md.)|December 2, 2017
ReplyMelania Gaggini, Elisabetta Bugianesi, Amalia Gastaldelli
Hepatobiliary Surgery and Nutrition|May 26, 2015
Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destructionMetin Basaranoglu, Gokcen Basaranoglu, Elisabetta Bugianesi
Journal of Hepatology|February 4, 2012
The interaction of metabolic factors with HCV infection: does it matter?Elisabetta Bugianesi, Federico Salamone, Francesco Negro
Hepatology (Baltimore, Md.)|October 27, 2005
Insulin resistance: a metabolic pathway to chronic liver diseaseElisabetta Bugianesi, Arthur J McCullough, Giulio Marchesini
Pageof 33

Showing results (21-30 of 326) with videos related to

Sort By:
Pageof 33
Current Diabetes Reports|June 6, 2007
NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetesElisabetta Bugianesi, Ester Vanni, Giulio Marchesini
The American Journal of Gastroenterology|March 15, 2018
Reply to "Definition of Small for Gestational Age and Low Birthweight"Valerio Nobili, Antonella Mosca, Elisabetta Bugianesi
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 29, 2015
Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?Ester Vanni, Elisabetta Bugianesi, Giorgio Saracco
Liver International : Official Journal of the International Association for the Study of the Liver|October 16, 2024
Impact of PNPLA3 I148M on Clinical Outcomes in Patients With MASLDSalvatore Petta, Angelo Armandi, Elisabetta Bugianesi
Annual Review of Medicine|October 17, 2015
Liver Cancer: Connections with Obesity, Fatty Liver, and CirrhosisAndrea Marengo, Chiara Rosso, Elisabetta Bugianesi
Annals of Medicine|September 24, 2005
Is liver disease a threat to patients with metabolic disorders?Giulio Marchesini, Gabriele Forlani, Elisabetta Bugianesi
Hepatology (Baltimore, Md.)|December 2, 2017
ReplyMelania Gaggini, Elisabetta Bugianesi, Amalia Gastaldelli
Hepatobiliary Surgery and Nutrition|May 26, 2015
Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destructionMetin Basaranoglu, Gokcen Basaranoglu, Elisabetta Bugianesi
Journal of Hepatology|February 4, 2012
The interaction of metabolic factors with HCV infection: does it matter?Elisabetta Bugianesi, Federico Salamone, Francesco Negro
Hepatology (Baltimore, Md.)|October 27, 2005
Insulin resistance: a metabolic pathway to chronic liver diseaseElisabetta Bugianesi, Arthur J McCullough, Giulio Marchesini
Pageof 33